PSAD is calculated as the quotient of the serum PSA level and the prostate volume and shows an improvement of diagnostic accuracy over PSA, but its use for early PCa diagnosis is to date not commonly recommended in guidelines [6]. The gene discussed is KLK3; the disease is posterior cortical atrophy.